Dr. Naglaa Fathy, esteemed Head of Regulatory Affairs at Novartis Egypt, is a distinguished leader in the field of regulatory affairs. With over 20 years of experience in the pharmaceutical industry, she has been pivotal in advancing innovative pharmaceutical and biological products, generics, and biosimilars, including import, local manufacturing, and export activities. She holds a bachelor’s degree in Pharmaceutical Sciences from Helwan University and an International Diploma in Business Administration from Cambridge. Known for her commitment to excellence, compliance and harmonization, Dr. Naglaa maintains strong relationships with health authorities. As Co-Chair of the Regulatory Working Group at the Egyptian Foundation of Pharmaceutical Research (EFPR), she leads key discussions between the industry and regulators. Dr. Naglaa envisions regulatory excellence as a catalyst for innovation and accessibility in the pharmaceutical sector. She is dedicated to fostering collaboration and empowering regulatory personal, constantly striving to enhance patient outcomes and public health.